Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients With Ventilator Associated-pneumonia
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to compare the median exposures at pharmacokinetic
equilibrium of the two modalities of administration: 4-hours infusion of
ceftolozane-tazobactam at a dosage of 2 gram three times a day vs 1-hour infusion of 2 gram
three times a day.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Toulouse
Treatments:
Ceftolozane, tazobactam drug combination Cephalosporins Penicillanic Acid Pharmaceutical Solutions Tazobactam